Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical Management.
- DOI
- 10.1007/s11864-026-01402-3
- Published
- 2026 Jul 9
- Container
- Current treatment options in oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11864-026-01402-3,
title = {Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical Management.},
author = {Lin M and Shi S and Zhang C and Yang J and Dong R and Lin N and Tong X and Li Y},
year = {2026},
journal = {Current treatment options in oncology},
doi = {10.1007/s11864-026-01402-3},
url = {https://doi.org/10.1007/s11864-026-01402-3}
}RIS
TY - JOUR TI - Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical Management. AU - Lin M AU - Shi S AU - Zhang C AU - Yang J AU - Dong R AU - Lin N AU - Tong X AU - Li Y PY - 2026 JO - Current treatment options in oncology DO - 10.1007/s11864-026-01402-3 UR - https://doi.org/10.1007/s11864-026-01402-3 ER -
APA
M, L., S, S., C, Z., J, Y., R, D., N, L., X, T., & Y, L. (2026). Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical Management.. Current treatment options in oncology. https://doi.org/10.1007/s11864-026-01402-3
Source records
- pubmed · retrieved 2026-09-26T12:53:09.080Z